Human Umbilical Cord-Derived Mesenchymal Stem Cells Do Not Undergo Malignant Transformation during Long-Term Culturing in Serum-Free Medium

Background Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) are in the foreground as a preferable application for treating diseases. However, the safety of hUC-MSCs after long-term culturing in vitro in serum-free medium remains unclear. Methods hUC-MSCs were separated by adherent tissue culture. hUC-MSCs were cultured in serum-free MesenCult-XF medium and FBS-bases DMEM complete medium. At the 1st, 3rd, 5th, 8th, 10th, and 15th passage, the differentiation of MSCs into osteogenic, chondrogenic, and adipogenic cells was detected, and MTT, surface antigens were measured. Tumorigenicity was analyzed at the 15th passage. Conventional karyotyping was performed at passage 0, 8, and 15. The telomerase activity of hUC-MSCs at passage 1–15 was analyzed. Results Flow cytometry analysis showed that very high expression was detected for CD105, CD73, and CD90 and very low expression for CD45, CD34, CD14, CD79a, and HLA-DR. MSCs could differentiate into osteocytes, chondrocytes, and adipocytes in vitro. There was no obvious chromosome elimination, displacement, or chromosomal imbalance as determined from the guidelines of the International System for Human Cytogenetic Nomenclature. Telomerase activity was down-regulated significantly when the culture time was prolonged. Further, no tumors formed in rats injected with hUC-MSCs (P15) cultured in serum-free and in serum-containing conditions. Conclusion Our data showed that hUC-MSCs met the International Society for Cellular Therapy standards for conditions of long-term in vitro culturing at P15. Since hUC-MSCs can be safely expanded in vitro and are not susceptible to malignant transformation in serum-free medium, these cells are suitable for cell therapy.

[1]  Dolores Baksh,et al.  Human Umbilical Cord Perivascular (HUCPV) Cells: A Source of Mesenchymal Progenitors , 2005, Stem cells.

[2]  M. Miloso,et al.  From cytogenomic to epigenomic profiles: monitoring the biologic behavior of in vitro cultured human bone marrow mesenchymal stem cells , 2012, Stem Cell Research & Therapy.

[3]  C. Herberts,et al.  Risk factors in the development of stem cell therapy , 2011, Journal of Translational Medicine.

[4]  G. Semenza,et al.  Spontaneous transformation of cultured mouse bone marrow-derived stromal cells. , 2006, Cancer research.

[5]  J. Adjaye,et al.  Human Stromal (Mesenchymal) Stem Cells from Bone Marrow, Adipose Tissue and Skin Exhibit Differences in Molecular Phenotype and Differentiation Potential , 2012, Stem Cell Reviews and Reports.

[6]  D. Lai,et al.  Isolation and Characterization of a Novel Strain of Mesenchymal Stem Cells from Mouse Umbilical Cord: Potential Application in Cell-Based Therapy , 2013, PloS one.

[7]  R. Bjerkvig,et al.  Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: putting the research field on track - letter. , 2010, Cancer research.

[8]  M. Weiss,et al.  Musculoskeletal tissue engineering with human umbilical cord mesenchymal stromal cells. , 2011, Regenerative medicine.

[9]  A. Monabati,et al.  Adipose Tissue Derived Multipotent Mesenchymal Stromal Cells Can Be Isolated Using Serum-free Media , 2013, Iranian Red Crescent medical journal.

[10]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[11]  Y. Even,et al.  Prolonged self-renewal activity unmasks telomerase control of telomere homeostasis and function of mouse hematopoietic stem cells , 2011 .

[12]  I. Fuentes,et al.  Umbilical cord as a mesenchymal stem cell source for treating joint pathologies. , 2011, World journal of orthopedics.

[13]  R. Bjerkvig,et al.  Comment to: "Spontaneous transformation of adult mesenchymal stem cells from cynomolgus macaques in vitro" by Z. Ren et al. Exp. Cell Res. 317 (2011) 2950-2957: spontaneous transformation of mesenchymal stem cells in culture: facts or fiction? , 2012, Experimental cell research.

[14]  B. Spencer‐Dene,et al.  Murine but Not Human Mesenchymal Stem Cells Generate Osteosarcoma‐Like Lesions in the Lung , 2007, Stem cells.

[15]  M. Weiss,et al.  Concise Review: Wharton's Jelly‐Derived Cells Are a Primitive Stromal Cell Population , 2008, Stem cells.

[16]  Longmei Zhao,et al.  Temporal HLA profiling and immunomodulatory effects of human adult bone marrow- and adipose-derived mesenchymal stem cells. , 2014, Regenerative medicine.

[17]  Rolf Bjerkvig,et al.  Spontaneous Transformation of Stem Cells In Vitro and the Issue of Cross-Contamination , 2012, International journal of biological sciences.

[18]  L. Tang,et al.  Characterization of bone marrow derived mesenchymal stem cells in suspension , 2012, Stem Cell Research & Therapy.

[19]  Q. Xie,et al.  Malignant Transformation Potentials of Human Umbilical Cord Mesenchymal Stem Cells Both Spontaneously and via 3-Methycholanthrene Induction , 2013, PloS one.

[20]  L. Bouzas,et al.  Stability of human mesenchymal stem cells during in vitro culture: considerations for cell therapy , 2013, Cell proliferation.

[21]  B. Meiser,et al.  Umbilical cord tissue-derived mesenchymal stem cells grow best under GMP-compliant culture conditions and maintain their phenotypic and functional properties. , 2010, Journal of immunological methods.

[22]  Mimmi Patrikoski,et al.  Development of fully defined xeno-free culture system for the preparation and propagation of cell therapy-compliant human adipose stem cells , 2013, Stem Cell Research & Therapy.

[23]  张静,et al.  Banana Ovate family protein MaOFP1 and MADS-box protein MuMADS1 antagonistically regulated banana fruit ripening , 2015 .

[24]  E. Tobiasch,et al.  Mechanisms Underlying the Osteo- and Adipo-Differentiation of Human Mesenchymal Stem Cells , 2012, TheScientificWorldJournal.

[25]  L. Sensébé.  Clinical grade production of mesenchymal stem cells. , 2008, Bio-medical materials and engineering.

[26]  Zhuang Liu,et al.  Drug delivery with carbon nanotubes for in vivo cancer treatment , 2008, 0808.2070.

[27]  Y. Hasegawa,et al.  EGFR-TKI resistance due to BIM polymorphism can be circumvented in combination with HDAC inhibition. , 2013, Cancer research.

[28]  M. Kay,et al.  Sarcoma Derived from Cultured Mesenchymal Stem Cells , 2007, Stem cells.

[29]  E. Syková,et al.  The role of mesenchymal stromal cells in spinal cord injury, regenerative medicine and possible clinical applications. , 2013, Biochimie.

[30]  P. Lønning,et al.  Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. , 2009, Cancer research.

[31]  Devang M Patel,et al.  Therapeutic Potential of Mesenchymal Stem Cells in Regenerative Medicine , 2013, Stem cells international.

[32]  A. Cometa,et al.  Human bone marrow-derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms , 2010 .

[33]  P. Lansdorp.  Telomeres, stem cells, and hematology. , 2008, Blood.